In our prior work, we substantiated that in cervical cancer patients exhibiting a high Tumor Mutational Burden (TMB), diminished Caspase-8 expression was associated with a dismal prognosis and resistance to conventional chemotherapeutic agents, specifically Carboplatin and Cisplatin. The gene discussed is CASP8; the disease is cervical cancer.